Amoxicillin And Clavulanate Potassium Powder, For Suspension
Product Images NDC 0093-8675

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 0093-8675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amoxicillin And Clavulanate Potassium Powder For S 1

Chemical structure of Amoxicillin and Clavulanate Potassium showing the molecular arrangement of atoms in the compound.*

FDA Label Image

Amoxicillin And Clavulanate Potassium Powder For S 2

Chemical structure diagram of the active ingredient Amoxicillin and Clavulanate Potassium, showing its molecular framework and functional groups.*

FDA Label Image

Amoxicillin And Clavulanate Potassium Powder For S 3

Label for Amoxicillin and Clavulanate Potassium oral suspension USP 600 mg/42.9 mg per 5 mL by Teva Pharmaceuticals USA, Inc. The label indicates it is a 200 mL powder for suspension, requiring reconstitution. It features dosage instructions, storage information, and a barcode on a white and green background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.